Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.
about
Systemic Immunotherapy for the Treatment of Brain MetastasesRecent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging(11)C[double bond, length as m-dash]O bonds made easily for positron emission tomography radiopharmaceuticalsSystemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Total Radiosynthesis: Thinking outside "the box"Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.Sequencing brain metastases and opportunities for targeted therapies.Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib.Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?
P2860
Q26750891-6CB2F4AF-62FA-4382-A60F-08C6B60858A2Q26774478-C8887491-A3B1-40F6-93DA-1AED2ED87488Q28066107-A16D5A40-06B6-4B4A-86F6-B5AFA04A569EQ30239901-51185398-0F81-4B9E-9122-29B688C88A6CQ33737278-19F9C3E7-FB35-4130-8470-509E521773F4Q36100908-D0AE7021-6B84-4ADE-A8E3-A45A35094A1AQ38715328-CBEA63B9-9D66-48AD-8275-89A664A71571Q38827063-BBACB7E2-28CD-4752-B33D-B2C77C7EE026Q39177404-868F945A-A096-405D-A878-1CF74F49EB47Q39775271-4073FD82-FE15-4E79-8915-2CBC7E8AD22EQ41601105-DFD044BC-9443-476F-8A9C-7D1FCB9A0EC1Q42751410-3748A10C-4D03-49C5-B070-7C081368B7DFQ49796158-27FCD796-980C-42EC-BD84-980718B11BC9Q50043843-21B0A55C-CC0D-451F-8E45-CF1DB3A1647E
P2860
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lapatinib access into normal b ...... overexpressing breast cancer.
@ast
Lapatinib access into normal b ...... overexpressing breast cancer.
@en
type
label
Lapatinib access into normal b ...... overexpressing breast cancer.
@ast
Lapatinib access into normal b ...... overexpressing breast cancer.
@en
prefLabel
Lapatinib access into normal b ...... overexpressing breast cancer.
@ast
Lapatinib access into normal b ...... overexpressing breast cancer.
@en
P2093
P2860
P1433
P1476
Lapatinib access into normal b ...... 2 overexpressing breast cancer
@en
P2093
Azeem Saleem
Carlo Palmieri
Charles Lowdell
Eric O Aboagye
Graham E Searle
Kasia Kozlowski
Laura M Kenny
Laura Woodley
Mickael Huiban
Mike R Lau
P2860
P2888
P356
10.1186/S13550-015-0103-5
P577
2015-04-30T00:00:00Z
P5875
P6179
1021364615